WASHINGTON (AP) — Federal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs.
WASHINGTON (AP) – The Supreme Court plunged into its new term Monday with a high-stakes dispute between businesses and human rights groups over accountability for foreign atrocities. The next nine months hold the prospect for […]
WASHINGTON (AP) – The Supreme Court appears ready to impose new limits on lawsuits brought in U.S. courts over human rights violations abroad. The justices kicked off their new term Monday with arguments over […]